February 4, 2011 -- Pierrel Research USA, Inc. Announces the Addition of Rhonda Rusinski, R.N., B.S.N. to the Medical Services Group Wayne, Pennsylvania, February 04, 2011 - Pierrel Research USA, Inc., the US subsidiary of Pierrel Research International AG, announced today that Rhonda Rusinski has joined the organization as Associate Director of a section of medical services dealing with Data Safety Management and Pharmacovigilance expansion. Ms. Rusinski has extensive experience in managing DSMB/DMC activities with over 100 such programs that she has implemented in the past three years. She also has an additional seven years of management in pharmacovigilance services during her time at a major global CRO.
“Rhonda has some of the most extensive experience in the field of DSMB work that I have ever seen,” said Michael Laird, CEO of Pierrel Research USA, Inc.
“The extent of her interactions with key opinion, clinical, statistical and steering committee leaders in multiple therapeutic areas is quite remarkable.”
With the addition of Ms. Rusinski, Pierrel Research International continues to improve on its extensive experience in the field of Drug Safety that includes work with product recalls, stand-alone pharmacovigilance services for large and small pharmaceutical and biotechnology firms, safety surveillance in Phases I-IV, Post-marketing and call center capabilities. Rhonda obtained her B.S. degree in nursing from Kutztown University and is a candidate for the Master of Science degree in Quality Assurance and Regulatory Affairs at Temple University.
About Pierrel Research International AG:
Pierrel Research International AG is a global contract research organization which operates both in Europe and the USA, providing consultancies and full services for research and development of new molecules and drug products. It is a wholly-owned subsidiary of Pierrel S.p.A. Pierrel S.p.A., a global provider to the pharmaceutical and life science industries, specializes in Research and development (Contract Research) and production (Contract Manufacturing) of drug products, and is listed on the Italian Stock Exchange. The Pierrel Group enjoys more than 50 years of experience in the pharmaceutical sector and is one of the main European manufacturers of dental anesthetic drug products. The manufacturing facility in Capua, Italy, near Naples, has been authorized by the FDA for the production of sterile small volumes parenteral drugs.
Pierrel Research USA, Inc. is located in Wayne, Pennsylvania.
For further information: Business Development Gary Goldberg at g.goldberg@pierrelgroup.com Tel. 610-975-9533 Pierrel S.p.A Corporate office is located in Milan, Italy.
For further information: Pierrel S.p.A. Investor Relations Dott. Aurelio Matrone Email: investor.relations@pierrelgroup.com tel. +39 02 2413491 fax +39 02 24134201 Image Building Simona Raffaelli, Emanuela Borromeo, Camilla Castaldo Tel. 02/8901.1300 E-mail: pierrel@imagebuilding.it
